 Administration, Oral
"Administration, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The giving of drugs, chemicals, or other substances by mouth.
| Descriptor ID |
D000284
|
| MeSH Number(s) |
E02.319.267.100
|
| Concept/Terms |
Administration, Oral- Administration, Oral
- Drug Administration, Oral
- Oral Drug Administration
- Oral Administration
- Administrations, Oral
- Oral Administrations
- Administration, Oral Drug
- Administrations, Oral Drug
- Drug Administrations, Oral
- Oral Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Oral".
Below are MeSH descriptors whose meaning is more specific than "Administration, Oral".
This graph shows the total number of publications written about "Administration, Oral" by people in this website by year, and whether "Administration, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 8 | 8 | | 1997 | 0 | 4 | 4 | | 1998 | 0 | 7 | 7 | | 1999 | 0 | 2 | 2 | | 2000 | 0 | 6 | 6 | | 2001 | 0 | 6 | 6 | | 2002 | 0 | 10 | 10 | | 2003 | 0 | 8 | 8 | | 2004 | 0 | 25 | 25 | | 2005 | 0 | 12 | 12 | | 2006 | 0 | 9 | 9 | | 2007 | 0 | 22 | 22 | | 2008 | 0 | 18 | 18 | | 2009 | 0 | 12 | 12 | | 2010 | 0 | 27 | 27 | | 2011 | 0 | 21 | 21 | | 2012 | 0 | 32 | 32 | | 2013 | 0 | 22 | 22 | | 2014 | 0 | 29 | 29 | | 2015 | 0 | 26 | 26 | | 2016 | 0 | 38 | 38 | | 2017 | 0 | 36 | 36 | | 2018 | 0 | 46 | 46 | | 2019 | 1 | 37 | 38 | | 2020 | 0 | 33 | 33 | | 2021 | 0 | 27 | 27 | | 2022 | 0 | 6 | 6 | | 2023 | 0 | 8 | 8 | | 2024 | 0 | 19 | 19 | | 2025 | 0 | 32 | 32 | | 2026 | 0 | 9 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Administration, Oral" by people in Profiles.
-
Cotter JM, Dunn A, Williams DJ, Ramgopal S, Fritz CQ, Taft M, Hall M, Temte E, Stassun J, Trivedi K, Kapes J, Lavey J, Coon E, Kempe A, Ambroggio L. Children Hospitalized With Pneumonia Who Complete Oral Antibiotic Treatment Without Complications. Hosp Pediatr. 2026 May 01; 16(5):e316-e322.
-
Hibberd PL, Kim JH, Trotta M, Leal SM, Aceituno A, Ward DV, Patel A, Subramaniam A, Carlo WA, Ahmed I, Saleem S, Billah SM, Haque R, Mazariegos M, Esamai F, Somannavar MS, Goudar SS, Chomba E, Mwenchanya M, Lokangaka A, Tshefu A, Goldenberg RL, Bauserman M, Krebs NF, Bucher S, Derman RJ, Petri WA, Koso-Thomas M, Babineau DC, McClure EM, Tita ATN. Impact of prophylactic oral azithromycin during labor on Azithromycin Resistance (AMR) in nasal Staphylococcus aureus and Streptococcus pneumoniae in women and infants in the multi-country Azithromycin Prevention in Labor Use Study (A-PLUS). PLoS One. 2026; 21(4):e0346174.
-
Pham TH, Molina KC, Huang V. Predicting oral cephalosporin susceptibility in Escherichia coli blood isolates using parenteral cephalosporin susceptibility testing. J Antimicrob Chemother. 2026 Mar 04; 81(4).
-
Mhlanga FG, Szydlo DW, Mayo AJ, Bunge K, Fairlie L, Nakabiito C, Musara P, Mgodi NM, Dadabhai S, Scheckter R, Anderson PL, Marzinke MA, Chappell C, Gadama LA, Richardson BA, Piper JM, Hillier SL. Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial. Lancet HIV. 2026 Mar; 13(3):e176-e184.
-
Sindher SB, Chehade M, Dellon ES, Jones SM, Spergel JM, Lin A, Rogers NH, Wood RA, Shreffler WG, Burk CM, Kim EH, Virkud YV, Scurlock AM, Lanser BJ, Hui-Beckman JW, Vickery BP, Bird JA, Parrish C, Wang J, Sicherer SH, Brown-Whitehorn T, Dantzer J, Ruiz J, Wheatley LM, Chinthrajah RS. Management of Gastrointestinal Symptoms During Oral Immunotherapy: Guidance from OUtMATCH Investigators. J Allergy Clin Immunol Pract. 2026 Apr; 14(4):772-779.
-
You L, Parikh HM, Triolo TM, Ferrat LA, Templeman EL, Oram RA, Gottlieb PA, Rich SS, Onengut-Gumuscu S, Steck AK, Krischer J, Redondo MJ. Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes Prevention. Diabetes Care. 2026 Feb 01; 49(2):344-351.
-
Gomez Wulschner LE, Chang VN, Oh WC, Bates EA. Oral Consumption of Cannabidiol During Pregnancy Alters Behavior in Mouse Offspring. Cannabis Cannabinoid Res. 2026 Apr; 11(2):130-137.
-
Moore CF, Bergeria CL, Sempio C, Klawitter J, Christians U, Weerts EM. High doses of orally administered cannabigerol produce deficits in sustained attention in female rats. Pharmacol Biochem Behav. 2026 Mar; 260:174154.
-
Shah MM, Abedi GR, Lu S, Garcia-Knight M, Pineda-Ramirez J, Goldberg SA, Grijalva CG, Keipp Talbot H, Schmitz J, Lutrick K, Ellingson KD, Stockwell MS, Sano E, Nguyen HQ, Rao S, Asturias EJ, Suthar MS, Mellis AM, Deeks SG, Martin JN, Peluso MJ, Andino R, Rolfes MA, Kirking HL, Smith-Jeffcoat SE, Midgley CM, Hagen MB, Kelly JD. SARS-CoV-2 infectious shedding and rebound among adults with and without oral antiviral use: two case-ascertained prospective household studies. Lancet Microbe. 2026 Jan; 7(1):101227.
-
Lehenbauer KS, Nelson AJ, Nodari S, Sverdlov AL, Harrington J. The impact of oral semaglutide on cardiovascular events in patients with type 2 diabetes: review of results from the SOUL trial. Heart Fail Rev. 2025 Dec 10; 31(1):11.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|